BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38238876)

  • 1. FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis.
    Zhao M; Ma T; Zhang Z; Wang Y; Wang X; Wang W; Chen X; Gao R; Shan L
    Animal Model Exp Med; 2024 Jan; ():. PubMed ID: 38238876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection.
    Sun T; Wang H; Li Q; Qian Z; Shen C
    Jpn J Clin Oncol; 2016 Mar; 46(3):209-21. PubMed ID: 26732382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXK1, Regulated by miR-365-3p, Promotes Cell Growth and EMT Indicates Unfavorable Prognosis in Breast Cancer.
    Gao F; Tian J
    Onco Targets Ther; 2020; 13():623-634. PubMed ID: 32021304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer.
    Li L; Gong M; Zhao Y; Zhao X; Li Q
    Oncotarget; 2017 Sep; 8(41):70441-70451. PubMed ID: 29050292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma.
    Li X; Lu J; Liu L; Li F; Xu T; Chen L; Yan Z; Li Y; Guo W
    Sci Rep; 2023 May; 13(1):7737. PubMed ID: 37173384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor.
    Xie G; Liu X; Zhang Y; Li W; Liu S; Chen Z; Xu B; Yang J; He L; Zhang Z; Jin T; Yi X; Sun L; Shang Y; Liang J
    Oncogene; 2017 Sep; 36(39):5497-5511. PubMed ID: 28534508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
    Yang H; Song Z; Wu X; Wu Y; Liu C
    Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
    Wu Y; Xie R; Liu X; Wang J; Peng Y; Tang W; Wu M; Zhang P; Ba Y; Zhao J; Li A; Nan Q; Chen Y; Liu S; Wang J
    Oncol Rep; 2016 Oct; 36(4):2151-9. PubMed ID: 27571921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.
    Liu J; Zhang J; Wang Z; Xi J; Bai L; Zhang Y
    Cancer Biother Radiopharm; 2021 Nov; 36(9):737-752. PubMed ID: 32343603
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.
    Peng Y; Zhang P; Huang X; Yan Q; Wu M; Xie R; Wu Y; Zhang M; Nan Q; Zhao J; Li A; Xiong J; Ren Y; Bai Y; Chen Y; Liu S; Wang J
    Cell Death Dis; 2016 Nov; 7(11):e2480. PubMed ID: 27882939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.
    Li B; Lou G; Zhang J; Cao N; Yu X
    BMC Cancer; 2022 Jan; 22(1):124. PubMed ID: 35100978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancer.
    Xie R; Wang J; Liu X; Wu L; Zhang H; Tang W; Li Y; Xiang L; Peng Y; Huang X; Bai Y; Liu G; Li A; Wang Y; Chen Y; Ren Y; Li G; Gong W; Liu S; Wang J
    Sci Rep; 2017 Jun; 7(1):3709. PubMed ID: 28623323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis.
    Wang N; He JX; Jia GZ; Wang K; Zhou S; Wu T; He XL
    Cancer Cell Int; 2020 Dec; 20(1):553. PubMed ID: 33298041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
    Wang L; Yi J; Lu LY; Zhang YY; Wang L; Hu GS; Liu YC; Ding JC; Shen HF; Zhao FQ; Huang HH; Liu W
    Theranostics; 2021; 11(4):1732-1752. PubMed ID: 33408778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC3-ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway.
    Park SH; Kim H; Kwak S; Jeong JH; Lee J; Hwang JT; Choi HK; Choi KC
    Cells; 2020 May; 9(5):. PubMed ID: 32455774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FOXK1-CCDC43 Axis Promotes the Invasion and Metastasis of Colorectal Cancer Cells.
    Wang J; Liu G; Liu M; Xiang L; Xiao Y; Zhu H; Wu X; Peng Y; Zhang W; Jiang P; Li A; Nan Q; Chen Y; Chen C; Cheng T; Liu S; Wang J
    Cell Physiol Biochem; 2018; 51(6):2547-2563. PubMed ID: 30562730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXK1 regulates epithelial-mesenchymal transition and radiation sensitivity in nasopharyngeal carcinoma via the JAK/STAT3 signaling pathway.
    Duan L; Huang J; Zhang Y; Pi G; Ying X; Zeng F; Hu D; Ma J
    Genes Genomics; 2023 Jun; 45(6):749-761. PubMed ID: 37043129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.